Client News Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the…News EditorOctober 18, 2021
Company AwardsCompany News Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious…News EditorAugust 10, 2021
Client NewsCompany News Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market…News EditorJuly 9, 2021
Client News Avance Clinical Client XWPharma Announces Positive Results from Phase 1 Clinical Trials of XW10172, in Development as Once-Nightly Therapy for Sleep Disorders in Patients with Neurodegenerative Diseases The leading Australian CRO for international biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership…News EditorJuly 9, 2021
Company Video Andy Hu on Avance Clinical – why it is the right CRO for Chinese Biotechs News EditorJuly 2, 2021